SCHEDULE 13G: Wellington Management Group Discloses 10.7% Stake in Qiagen N.V.

Wellington Management Group LLP and its affiliated entities have reported a significant beneficial ownership stake of 10.7% in Qiagen N.V. common stock.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP, has filed a Schedule 13G indicating beneficial ownership of 23,291,538 shares of Qiagen N.V. common stock.
• This aggregate beneficial ownership represents 10.7% of Qiagen N.V.'s outstanding common stock.
• Within this group, Wellington Management Company LLP directly holds shared voting power over 13,367,076 shares and shared dispositive power over 14,178,191 shares, representing 6.5% of the class.
• The reporting persons collectively hold shared voting power over 18,485,559 shares and shared dispositive power over 23,291,538 shares.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Qiagen N.V.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, providing no positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investment in Qiagen N.V., a company operating in the life sciences and molecular diagnostics industry. Such disclosures are common for large asset managers like Wellington Management Group, reflecting their portfolio positions in publicly traded companies.

Stakeholder Impact

• Shareholders: Disclosure of a significant institutional stake can influence investor perception and potentially stock liquidity.

Key Dates

Keywords

Qiagen N.V., Wellington Management Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Asset Management